There are also new formulations that act on other receptors in addition to GLP-1 receptors to significantly increase the medication's effectiveness , in some cases doubling the weight reduction patients experience
Theres so much interest, [researchers studying virtually] every disease are looking at GLP-1s, Dushay says
This pharmacologic effect, while beneficial for glycemic control and satiety, has prompted discussions about potential safety considerations during procedures requiring sedation or anesthesia
Retatrutide (Triple Agonist): Mimics the two hormones above plus a third: Glucagon
Researchers explore Retatrutide in laboratory environments examining metabolic regulation, energy expenditure, and endocrine signaling
For a 4mg dose, you would draw 0.8ml, or 80 units